Top

Cancer Causes & Control

Published in:

Open Access 01-05-2020 | Breast Cancer | Review article

The impact of lifestyle and reproductive factors on the risk of a second new primary cancer in the contralateral breast: a systematic review and meta-analysis

Authors: Delal Akdeniz, M. Maria Klaver, Chloé Z. A. Smith, Linetta B. Koppert, Maartje J. Hooning

Published in: Cancer Causes & Control | Issue 5/2020

Abstract

Purpose

The risk of being diagnosed with contralateral breast cancer (CBC) is an important health issue among breast cancer survivors. There is an increasing interest in the effect of lifestyle and reproductive factors on CBC risk, since these factors may partly be modifiable. We performed a systematic review and meta-analysis and aimed to evaluate the impact of lifestyle and reproductive factors on CBC risk in population-based breast cancer studies.

Methods

The PubMed electronic database was searched up to 2nd November 2019, for relevant publications. Of the included studies, a meta-analysis per lifestyle or reproductive factor was performed.

Results

Thirteen out of 784 publications were used for the meta-analysis. Body mass index (≥ 25 vs. < 25 kg/m²; RR = 1.22; 95% CI 1.01–1.47) was associated with increased CBC risk. The estimates for alcohol use (ever vs. never; RR = 1.15; 95% CI 1.02–1.31) and age at primiparity (≥ 25 vs. < 25 years; RR = 1.06; 95% CI 1.02–1.10) also showed an association with increased CBC risk. For parity (≥ 4 vs. nulliparous; RR = 0.56; 95% CI 0.42–0.76) and age at menopause (< 45 vs ≥ 45 years; RR = 0.79; 95% CI 0.67–0.93), results from two studies suggested a decreased CBC risk. We observed no association between CBC and smoking, age at menarche, oral contraceptive use, gravidity, breastfeeding, or menopausal status. Overall, the number of studies per risk factor was limited (n = 2–5).

Conclusions

BMI is a modifiable risk factor for CBC. Data on the effect of other modifiable lifestyle and reproductive factors are limited. For better counseling of patients on lifestyle effects, more studies are urgently needed.

Available only for authorised users

Integraal Kanker Centrum Nederland (2012) Cijfers over kanker. https://www.cijfersoverkanker.nl. Accessed 12 July 2017

SEER Stat Fact Sheets: Breast Cancer, 1975–2013. National Cancer Institute (2013) https://seer.cancer.gov/csr/1975_2013/. Accessed 2 Apr 2017

van den Broekvan 't Veer AJLJ, Hooning MJ, Cornelissen S, Broeks A, Rutgers EJ, Smit VT, Cornelisse CJ, van Beek M, Janssen-Heijnen ML, Seynaeve C, Westenend PJ, Jobsen JJ, Siesling S, Tollenaar RA, van Leeuwen FE, Schmidt MK (2016) Impact of age at primary breast cancer on contralateral breast cancer risk in BRCA1/2 mutation carriers. J Clin Oncol 34(5):409–418. https://doi.org/10.1200/JCO.2015.62.3942 CrossRefPubMed

Xiong Z, Yang L, Deng G, Huang X, Li X, Xie X, Wang J, Shuang Z, Wang X (2018) Patterns of occurrence and outcomes of contralateral breast cancer: analysis of SEER data. J Clin Med. https://doi.org/10.3390/jcm7060133 CrossRefPubMedPubMedCentral

Wong SM, Freedman RA, Sagara Y, Aydogan F, Barry WT, Golshan M (2017) Growing use of contralateral prophylactic mastectomy despite no improvement in long-term survival for invasive breast cancer. Ann Surg 265(3):581–589. https://doi.org/10.1097/SLA.0000000000001698 CrossRefPubMed

Murphy JA, Milner TD, O'Donoghue JM (2013) Contralateral risk-reducing mastectomy in sporadic breast cancer. Lancet Oncol 14(7):e262–269. https://doi.org/10.1016/S1470-2045(13)70047-0 CrossRefPubMed

Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 62(10):1006–1012. https://doi.org/10.1016/j.jclinepi.2009.06.005 CrossRefPubMed

Witteveen A, Kwast AB, Sonke GS, IJzerman MJ, Siesling S (2015) Survival after locoregional recurrence or second primary breast cancer: impact of the disease-free interval. PLoS ONE 10(4):e0120832. https://doi.org/10.1371/journal.pone.0120832 CrossRefPubMedPubMedCentral

Greenland S, Longnecker MP (1992) Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 135(11):1301–1309CrossRef

10.

Shankar A, Roy S, Malik A, Kamal VK, Bhandari R, Kishor K, Mahajan M, Sachdev J, Jeyaraj P, Rath G (2015) Contralateral breast cancer: a clinico-pathological study of second primaries in opposite breasts after treatment of breast malignancy. Asian Pac J Cancer Prev 16(3):1207–1211CrossRef

11.

Brooks JD, John EM, Mellemkjaer L, Reiner AS, Malone KE, Lynch CF, Figueiredo JC, Haile RW, Shore RE, Bernstein JL, Bernstein L (2012) Body mass index and risk of second primary breast cancer: the WECARE Study. Breast Cancer Res Treat 131(2):571–580. https://doi.org/10.1007/s10549-011-1743-4 CrossRefPubMed

12.

Li CI, Daling JR, Porter PL, Tang MT, Malone KE (2009) Relationship between potentially modifiable lifestyle factors and risk of second primary contralateral breast cancer among women diagnosed with estrogen receptor-positive invasive breast cancer. J Clin Oncol 27(32):5312–5318. https://doi.org/10.1200/JCO.2009.23.1597 CrossRefPubMedPubMedCentral

13.

Figueiredo JC, Bernstein L, Capanu M, Malone KE, Lynch CF, Anton-Culver H, Stovall M, Bertelsen L, Haile RW, Bernstein JL (2008) Oral contraceptives, postmenopausal hormones, and risk of asynchronous bilateral breast cancer: the WECARE Study Group. J Clin Oncol 26(9):1411–1418. https://doi.org/10.1200/jco.2007.14.3081 CrossRefPubMed

14.

Li CI, Malone KE, Porter PL, Daling JR (2003) Epidemiologic and molecular risk factors for contralateral breast cancer among young women. Br J Cancer 89(3):513–518. https://doi.org/10.1038/sj.bjc.6601042 CrossRefPubMedPubMedCentral

15.

Cook LS, White E, Schwartz SM, McKnight B, Daling JR, Weiss NS (1996) A population-based study of contralateral breast cancer following a first primary breast cancer (Washington, United States). Cancer Causes Control 7(3):382–390CrossRef

16.

Knight JA, Bernstein L, Largent J, Capanu M, Begg CB, Mellemkjaer L, Lynch CF, Malone KE, Reiner AS, Liang X, Haile RW, Boice JD Jr, Bernstein JL (2009) Alcohol intake and cigarette smoking and risk of a contralateral breast cancer: The Women's Environmental Cancer and Radiation Epidemiology Study. Am J Epidemiol 169(8):962–968. https://doi.org/10.1093/aje/kwn422 CrossRefPubMedPubMedCentral

17.

Brooks JD, John EM, Mellemkjaer L, Lynch CF, Knight JA, Malone KE, Reiner AS, Bernstein L, Liang X, Shore RE, Stovall M, Bernstein JL (2016) Body mass index, weight change, and risk of second primary breast cancer in the WECARE study: influence of estrogen receptor status of the first breast cancer. Cancer Med 5(11):3282–3291. https://doi.org/10.1002/cam4.890 CrossRefPubMedPubMedCentral

18.

Majed B, Dozol A, Ribassin-Majed L, Senouci K, Asselain B (2011) Increased risk of contralateral breast cancers among overweight and obese women: a time-dependent association. Breast Cancer Res Treat 126(3):729–738. https://doi.org/10.1007/s10549-010-1153-z CrossRefPubMed

19.

Trentham-Dietz A, Newcomb PA, Nichols HB, Hampton JM (2007) Breast cancer risk factors and second primary malignancies among women with breast cancer. Breast Cancer Res Treat 105(2):195–207. https://doi.org/10.1007/s10549-006-9446-y CrossRefPubMed

20.

Kuo WH, Yen AM, Lee PH, Hou MF, Chen SC, Chen KM, Chen TH, Chang KJ (2006) Incidence and risk factors associated with bilateral breast cancer in area with early age diagnosis but low incidence of primary breast cancer: analysis of 10-year longitudinal cohort in Taiwan. Breast Cancer Res Treat 99(2):221–228. https://doi.org/10.1007/s10549-006-9194-z CrossRefPubMed

21.

Dignam JJ, Wieand K, Johnson KA, Raich P, Anderson SJ, Somkin C, Wickerham DL (2006) Effects of obesity and race on prognosis in lymph node-negative, estrogen receptor-negative breast cancer. Breast Cancer Res Treat 97(3):245–254. https://doi.org/10.1007/s10549-005-9118-3 CrossRefPubMed

22.

Dignam JJ, Wieand K, Johnson KA, Fisher B, Xu L, Mamounas EP (2003) Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer. J Natl Cancer Inst 95(19):1467–1476CrossRef

23.

Bernstein JL, Thompson WD, Risch N, Holford TR (1992) Risk factors predicting the incidence of second primary breast cancer among women diagnosed with a first primary breast cancer. Am J Epidemiol 136(8):925–936CrossRef

24.

Knight JA, Fan J, Malone KE, John EM, Lynch CF, Langballe R, Bernstein L, Shore RE, Brooks JD, Reiner AS, Woods M, Liang X, Bernstein JL (2017) Alcohol consumption and cigarette smoking in combination: a predictor of contralateral breast cancer risk in the WECARE study. Int J Cancer 141(5):916–924. https://doi.org/10.1002/ijc.30791 CrossRefPubMedPubMedCentral

25.

Sisti JS, Bernstein JL, Lynch CF, Reiner AS, Mellemkjaer L, Brooks JD, Knight JA, Bernstein L, Malone KE, Woods M, Liang X, John EM (2015) Reproductive factors, tumor estrogen receptor status and contralateral breast cancer risk: results from the WECARE study. Springerplus 4:825. https://doi.org/10.1186/s40064-015-1642-y1642 CrossRefPubMedPubMedCentral

26.

Poynter JN, Langholz B, Largent J, Mellemkjaer L, Bernstein L, Malone KE, Lynch CF, Borg A, Concannon P, Teraoka SN, Xue S, Diep AT, Torngren T, Begg CB, Capanu M, Haile RW, Bernstein JL (2010) Reproductive factors and risk of contralateral breast cancer by BRCA1 and BRCA2 mutation status: results from the WECARE study. Cancer Causes Control : CCC 21(6):839–846. https://doi.org/10.1007/s10552-010-9510-0 CrossRefPubMed

27.

Figueiredo JC, Haile RW, Bernstein L, Malone KE, Largent J, Langholz B, Lynch CF, Bertelsen L, Capanu M, Concannon P, Borg A, Borresen-Dale AL, Diep A, Teraoka S, Torngren T, Xue S, Bernstein JL (2010) Oral contraceptives and postmenopausal hormones and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers and noncarriers: the WECARE Study. Breast cancer Res Treat 120(1):175–183. https://doi.org/10.1007/s10549-009-0455-5 CrossRefPubMed

28.

Largent JA, Capanu M, Bernstein L, Langholz B, Mellemkaer L, Malone KE, Begg CB, Haile RW, Lynch CF, Anton-Culver H, Wolitzer A, Bernstein JL (2007) Reproductive history and risk of second primary breast cancer: the WECARE study. Cancer Epidemiol Biomarkers Prev 16(5):906–911. https://doi.org/10.1158/1055-9965.EPI-06-1003 CrossRefPubMed

29.

Vaittinen P, Hemminki K (2000) Risk factors and age-incidence relationships for contralateral breast cancer. Int J Cancer 88(6):998–1002. https://doi.org/10.1002/1097-0215(20001215)88:6%3c998:AID-IJC25%3e3.0.CO;2-0 CrossRefPubMed

30.

Potischman N, Swanson CA, Siiteri P, Hoover RN (1996) Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status. J Nat Cancer Inst 88(11):756–758CrossRef

31.

Munsell MF, Sprague BL, Berry DA, Chisholm G, Trentham-Dietz A (2014) Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status. Epidemiol Rev 36:114–136. https://doi.org/10.1093/epirev/mxt010 CrossRefPubMedPubMedCentral

32.

Neuhouser ML, Aragaki AK, Prentice RL, Manson JE, Chlebowski R, Carty CL, Ochs-Balcom HM, Thomson CA, Caan BJ, Tinker LF, Urrutia RP, Knudtson J, Anderson GL (2015) Overweight, obesity, and postmenopausal invasive breast cancer risk: a secondary analysis of the women's health initiative randomized clinical trials. JAMA Oncol 1(5):611–621. https://doi.org/10.1001/jamaoncol.2015.1546 CrossRefPubMedPubMedCentral

33.

Key TJ, Appleby PN, Reeves GK, Roddam A, Dorgan JF, Longcope C, Stanczyk FZ, Stephenson HE Jr, Falk RT, Miller R, Schatzkin A, Allen DS, Fentiman IS, Key TJ, Wang DY, Dowsett M, Thomas HV, Hankinson SE, Toniolo P, Akhmedkhanov A, Koenig K, Shore RE, Zeleniuch-Jacquotte A, Berrino F, Muti P, Micheli A, Krogh V, Sieri S, Pala V, Venturelli E, Secreto G, Barrett-Connor E, Laughlin GA, Kabuto M, Akiba S, Stevens RG, Neriishi K, Land CE, Cauley JA, Kuller LH, Cummings SR, Helzlsouer KJ, Alberg AJ, Bush TL, Comstock GW, Gordon GB, Miller SR, Longcope C, EHBC Collaborative G (2003) Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Nat Cancer Inst 95(16):1218–1226CrossRef

34.

Simapivapan P, Boltong A, Hodge A (2016) To what extent is alcohol consumption associated with breast cancer recurrence and second primary breast cancer?: a systematic review. Cancer Treat Rev 50:155–167. https://doi.org/10.1016/j.ctrv.2016.09.010 CrossRefPubMed

35.

Lambe M, Hsieh CC, Chan HW, Ekbom A, Trichopoulos D, Adami HO (1996) Parity, age at first and last birth, and risk of breast cancer: a population-based study in Sweden. Breast cancer Res Treat 38(3):305–311CrossRef

36.

Russo J, Moral R, Balogh GA, Mailo D, Russo IH (2005) The protective role of pregnancy in breast cancer. Breast Cancer Res 7(3):131–142. https://doi.org/10.1186/bcr1029 CrossRefPubMedPubMedCentral

37.

Collaborative Group on Hormonal Factors in Breast C (2012) Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies. Lancet Oncol 13(11):1141–1151. https://doi.org/10.1016/S1470-2045(12)70425-4 CrossRef

38.

Chavez-MacGregor M, Elias SG, Onland-Moret NC, van der Schouw YT, Van Gils CH, Monninkhof E, Grobbee DE, Peeters PH (2005) Postmenopausal breast cancer risk and cumulative number of menstrual cycles. Cancer Epidemiol Biomarkers Prev 14(4):799–804. https://doi.org/10.1158/1055-9965.EPI-04-0465 CrossRefPubMed

39.

Key TJ, Verkasalo PK, Banks E (2001) Epidemiology of breast cancer. Lancet Oncol 2(3):133–140. https://doi.org/10.1016/S1470-2045(00)00254-0 CrossRefPubMed

40.

Ahn S, Becker BJ (2011) Incorporating quality scores in meta-analysis. J Educ Behav Stat 36(5):555–585. https://doi.org/10.3102/1076998610393968 CrossRef

41.

Greenland S, O'Rourke K (2001) On the bias produced by quality scores in meta-analysis, and a hierarchical view of proposed solutions. Biostatistics 2(4):463–471. https://doi.org/10.1093/biostatistics/2.4.463 CrossRefPubMed

42.

Akdeniz D, Schmidt MK, Seynaeve CM, McCool D, Giardiello D, van den Broek AJ, Hauptmann M, Steyerberg EW, Hooning MJ (2019) Risk factors for metachronous contralateral breast cancer: a systematic review and meta-analysis. Breast 44:1–14. https://doi.org/10.1016/j.breast.2018.11.005 CrossRefPubMed

43.

Reeves MM, Terranova CO, Eakin EG, Demark-Wahnefried W (2014) Weight loss intervention trials in women with breast cancer: a systematic review. Obes Rev 15(9):749–768. https://doi.org/10.1111/obr.12190 CrossRefPubMed

44.

Playdon M, Thomas G, Sanft T, Harrigan M, Ligibel J, Irwin M (2013) Weight loss intervention for breast cancer survivors: a systematic review. Curr Breast Cancer Rep 5(3):222–246. https://doi.org/10.1007/s12609-013-0113-0 CrossRefPubMedPubMedCentral

Title: The impact of lifestyle and reproductive factors on the risk of a second new primary cancer in the contralateral breast: a systematic review and meta-analysis
Authors: Delal Akdeniz
M. Maria Klaver
Chloé Z. A. Smith
Linetta B. Koppert
Maartje J. Hooning
Publication date: 01-05-2020
Publisher: Springer International Publishing
Keywords: Breast Cancer
Breast Cancer
Published in: Cancer Causes & Control / Issue 5/2020
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI: https://doi.org/10.1007/s10552-020-01284-2

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 5/2020

Diabetes and cardiovascular disease mortality among a population-based cohort of women with and without breast cancer

Evaluating the implementation of cervical cancer screening programs in low-resource settings globally: a systematized review

Maternal and perinatal characteristics, congenital malformations and the risk of wilms tumor: the ESTELLE study

Infectious mononucleosis, immune genotypes, and non-Hodgkin lymphoma (NHL): an InterLymph Consortium study

Systematic review and meta-analysis of the associations between body mass index, prostate cancer, advanced prostate cancer, and prostate-specific antigen

The association between type 2 diabetes mellitus and bladder cancer risk among postmenopausal women

Keynote webinar | Spotlight on antibody–drug conjugates in cancer